Profit and Loss Results Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
No of Months
12
12
Operating Income
635.00
453.00
Less :Inter divisional transfers
0.00
0.00
Less: Excise
0.00
0.00
Net Sales
635.00
453.00
Expenditure (Ex Depriciation)
Stock Adjustments
-31.00
6.00
Raw Materials Consumed
480.00
321.00
Power & Fuel Cost
5.00
4.00
Employee Cost
32.00
22.00
Operating Expenses
15.00
14.00
General and Administration Expenses
-1.00
-1.00
Selling and Distribution Expenses
7.00
5.00
Cost of Software developments
0.00
0.00
Miscellaneous Expenses
2.00
2.00
Expenses Capitalised
0.00
0.00
Total Expenditure
544.00
401.00
Operating Profit (PBDIT) excl Other Income
90.00
52.00
Other Income
3.00
2.00
Operating Profit (PBDIT)
94.00
54.00
Interest
39.00
22.00
Profit before Depriciation and Tax
55.00
32.00
Depreciation
8.00
5.00
Profit Before Taxation & Exceptional Items
46.00
27.00
Exceptional Income / Expenses
0.00
0.00
Profit Before Tax
46.00
27.00
Provision for Tax
14.00
7.00
Profit After Tax
32.00
19.00
Extraordinary Items
0.00
0.00
Adj to Profit After Tax
0.00
0.00
Profit Balance B/F
62.00
43.00
Profit Available for appropriations
95.00
63.00
Appropriations
95.00
63.00
Equity Dividend (%)
7.00%
7.00%
Earnings Per Share
66.81
41.78
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 40.03% vs NA in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 73.25% vs NA in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 75.62% vs NA in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 65.26% vs NA in Mar 2025
Compare Profit and Loss Results of Fredun Pharma
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
635.00
561.00
74.00
13.19%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
635.00
561.00
74.00
13.19%
Expenditure (Ex Depriciation)
Stock Adjustments
-31.00
-7.00
-24.00
-342.86%
Raw Materials Consumed
480.00
295.00
185.00
62.71%
Power & Fuel Cost
5.00
13.00
-8.00
-61.54%
Employee Cost
32.00
117.00
-85.00
-72.65%
Operating Expenses
15.00
36.00
-21.00
-58.33%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
7.00
50.00
-43.00
-86.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
2.00
13.00
-11.00
-84.62%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
544.00
581.00
-37.00
-6.37%
Operating Profit (PBDIT) excl Other Income
90.00
-19.00
109.00
573.68%
Other Income
3.00
81.00
-78.00
-96.30%
Operating Profit (PBDIT)
94.00
61.00
33.00
54.10%
Interest
39.00
2.00
37.00
1,850.00%
Profit before Depriciation and Tax
55.00
59.00
-4.00
-6.78%
Depreciation
8.00
24.00
-16.00
-66.67%
Profit Before Taxation & Exceptional Items
46.00
34.00
12.00
35.29%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
46.00
257.00
-211.00
-82.10%
Provision for Tax
14.00
7.00
7.00
100.00%
Profit After Tax
32.00
250.00
-218.00
-87.20%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
62.00
-388.00
450.00
115.98%
Profit Available for appropriations
95.00
-137.00
232.00
169.34%
Appropriations
95.00
-137.00
232.00
169.34%
Equity Dividend (%)
7%
0%
7.00
Earnings Per Share
66.81
37.25
29.56
79.36%
Profit And Loss - Net Sales
Net Sales 635.47 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 40.03% vs NA in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 90.88 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 73.25% vs NA in Mar 2025
Profit And Loss - Interest
Interest 39.30 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 75.62% vs NA in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 32.62 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 65.26% vs NA in Mar 2025
